Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kirn

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Gene Therapy|April 21, 2001
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?D Kirn
Expert Opinion on Biological Therapy|December 1, 2001
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trialsD Kirn
Oncogene|June 28, 2001
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancerD Kirn
Ernst Schering Research Foundation Workshop|August 5, 2003
Oncolytic virotherapy as a novel treatment platform for cancerD Kirn
Nature Medicine|September 2, 1999
Induction of an oncogenic fusion protein by a viral gene--a new chapter in an old storyD Kirn, T Hermiston
Gene Therapy|April 18, 2008
Gene therapy progress and prospects cancer: oncolytic virusesT-C Liu, D Kirn
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Pulmonary aspergillosis masquerading as progressive post-transplant lymphomaD Kirn, A Venook, I Pena
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administrationC Heise, M Lemmon, D Kirn
Nature Medicine|December 10, 1998
ONYX-015: clinical data are encouragingD Kirn, T Hermiston, F McCormick
Nature Medicine|July 4, 2001
Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsD Kirn, R L Martuza, J Zwiebel
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Gene Therapy|April 21, 2001
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?D Kirn
Expert Opinion on Biological Therapy|December 1, 2001
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trialsD Kirn
Oncogene|June 28, 2001
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancerD Kirn
Ernst Schering Research Foundation Workshop|August 5, 2003
Oncolytic virotherapy as a novel treatment platform for cancerD Kirn
Nature Medicine|September 2, 1999
Induction of an oncogenic fusion protein by a viral gene--a new chapter in an old storyD Kirn, T Hermiston
Gene Therapy|April 18, 2008
Gene therapy progress and prospects cancer: oncolytic virusesT-C Liu, D Kirn
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Pulmonary aspergillosis masquerading as progressive post-transplant lymphomaD Kirn, A Venook, I Pena
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administrationC Heise, M Lemmon, D Kirn
Nature Medicine|December 10, 1998
ONYX-015: clinical data are encouragingD Kirn, T Hermiston, F McCormick
Nature Medicine|July 4, 2001
Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsD Kirn, R L Martuza, J Zwiebel
Pageof 4